Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Allsop

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Substance Abuse and Rehabilitation|January 30, 2014
Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidenceKate Dolan, Shabnam Salimi, Bijan Nassirimanesh, et al.
Free Radical Biology & Medicine|May 29, 2002
Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's diseaseBrian J Tabner, Stuart Turnbull, Omar M A El-Agnaf, et al.
Journal of Women'S Health (2002)|September 13, 2011
Characteristics of Iranian women seeking drug treatmentKate Dolan, Shabnam Salimi, Bijan Nassirimanesh, et al.
Journal of Neurology|October 17, 2019
Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysisGlen P Martin, Kathryn R McDonald, David Allsop, et al.
The Journal of Biological Chemistry|March 13, 2014
β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen speciesJennifer Mayes, Claire Tinker-Mill, Oleg Kolosov, et al.
Brain Research|August 19, 2007
An investigation into the lipid-binding properties of alpha-, beta- and gamma-synucleins in human brain and cerebrospinal fluidSultan A Salem, David Allsop, David M A Mann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2010
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patientsHiroaki Fukumoto, Takahiko Tokuda, Takashi Kasai, et al.
Protein and Peptide Letters|June 9, 2004
Alpha-synuclein and the pathogenesis of Parkinson's diseaseFrancis L Martin, Sally J M Williamson, Katerina E Paleologou, et al.
Free Radical Research|September 21, 2006
A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synucleinBrian J Tabner, Stuart Turnbull, Jenny E King, et al.
Molecular Neurodegeneration|September 5, 2017
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndromeHarutsugu Tatebe, Takashi Kasai, Takuma Ohmichi, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Substance Abuse and Rehabilitation|January 30, 2014
Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidenceKate Dolan, Shabnam Salimi, Bijan Nassirimanesh, et al.
Free Radical Biology & Medicine|May 29, 2002
Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's diseaseBrian J Tabner, Stuart Turnbull, Omar M A El-Agnaf, et al.
Journal of Women'S Health (2002)|September 13, 2011
Characteristics of Iranian women seeking drug treatmentKate Dolan, Shabnam Salimi, Bijan Nassirimanesh, et al.
Journal of Neurology|October 17, 2019
Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysisGlen P Martin, Kathryn R McDonald, David Allsop, et al.
The Journal of Biological Chemistry|March 13, 2014
β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen speciesJennifer Mayes, Claire Tinker-Mill, Oleg Kolosov, et al.
Brain Research|August 19, 2007
An investigation into the lipid-binding properties of alpha-, beta- and gamma-synucleins in human brain and cerebrospinal fluidSultan A Salem, David Allsop, David M A Mann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2010
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patientsHiroaki Fukumoto, Takahiko Tokuda, Takashi Kasai, et al.
Protein and Peptide Letters|June 9, 2004
Alpha-synuclein and the pathogenesis of Parkinson's diseaseFrancis L Martin, Sally J M Williamson, Katerina E Paleologou, et al.
Free Radical Research|September 21, 2006
A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synucleinBrian J Tabner, Stuart Turnbull, Jenny E King, et al.
Molecular Neurodegeneration|September 5, 2017
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndromeHarutsugu Tatebe, Takashi Kasai, Takuma Ohmichi, et al.
Pageof 7